{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:34:50Z","timestamp":1785803690484,"version":"3.56.0"},"reference-count":47,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Deficiency of adenosine deaminase 2 (DADA2) has been a challenging diagnosis to make since it was first described in 2014. The disease represents a wide range of phenotypes. Therefore, it may present with various clinical patterns. Throughout the years, several difficult-to-diagnose cases of DADA2 were reported in the literature. Although several studies and reviews were published regarding different phenotypes and manifestations of DADA2, a review of challenging cases with diverse combinations of DADA2 manifestations was needed to integrate the knowledge from the literature into the clinical practice. Immunological, hematologic, autoinflammatory, and adult-onset polyarteritis-nodosa patterns were reported in the literature as cases challenging to diagnose. In this review, we aim to summarize the challenging case reports from the literature, provide an algorithmic approach for these kinds of presentations, and share our perspective and recommendations on the topic. Diagnosing DADA2 on time is a vital issue for preventing fatal and debilitating vascular events with anti-TNF-alpha therapy. Thus, early testing for DADA2 in suspected cases is recommended. Family history and genetic testing of the patient and the first-degree relatives are essential for accurate diagnosis. Thorough systemic examination and imaging might help detect clinically silent findings of vasculitis. Enzymatic activity of ADA2, when available, is also a key diagnostic tool that complements genetic testing and clinical evaluation.<\/jats:p>","DOI":"10.1093\/cei\/uxaf017","type":"journal-article","created":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T08:25:45Z","timestamp":1742718345000},"source":"Crossref","is-referenced-by-count":1,"title":["Mimics and challenging presentations of DADA2"],"prefix":"10.1093","volume":"219","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7224-087X","authenticated-orcid":false,"given":"Admir","family":"\u00d6zt\u00fcrk","sequence":"first","affiliation":[{"name":"Medicine, Cerrahpasa Medical Faculty, University of Istanbul-Cerrahpasa , Istanbul ,","place":["T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4259-9205","authenticated-orcid":false,"given":"Lara","family":"Yagci","sequence":"additional","affiliation":[{"name":"Medicine, Cerrahpasa Medical Faculty, University of Istanbul-Cerrahpasa , Istanbul ,","place":["T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9561-2282","authenticated-orcid":false,"given":"Serdal","family":"Ugurlu","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical Faculty, University of Istanbul-Cerrahpasa , Istanbul ,","place":["T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,3,21]]},"reference":[{"key":"2025050906463368900_CIT0001","doi-asserted-by":"publisher","first-page":"935957","DOI":"10.3389\/fimmu.2022.935957","article-title":"Adenosine deaminase 2 deficiency (DADA2): a crosstalk between innate and adaptive immunity","volume":"13","author":"Signa","year":"2022","journal-title":"Front Immunol"},{"key":"2025050906463368900_CIT0002","doi-asserted-by":"publisher","first-page":"101844","DOI":"10.1016\/j.berh.2023.101844","article-title":"Deficiency of adenosine deaminase 2 (DADA2): review","volume":"37","author":"Sharma","year":"2023","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2025050906463368900_CIT0003","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1056\/NEJMoa1307362","article-title":"Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy","volume":"370","author":"Navon Elkan","year":"2014","journal-title":"N Engl J Med"},{"key":"2025050906463368900_CIT0004","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1056\/NEJMoa1307361","article-title":"Early-onset stroke and vasculopathy associated with mutations in ADA2","volume":"370","author":"Zhou","year":"2014","journal-title":"N Engl J Med"},{"key":"2025050906463368900_CIT0005","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s10875-018-0525-8","article-title":"Deficiency of adenosine deaminase 2 (DADA2): updates on the phenotype, genetics, pathogenesis, and treatment","volume":"38","author":"Meyts","year":"2018","journal-title":"J Clin Immunol"},{"key":"2025050906463368900_CIT0006","doi-asserted-by":"publisher","first-page":"3883","DOI":"10.1007\/s10067-021-05711-w","article-title":"Expanding spectrum of DADA2: a review of phenotypes, genetics, pathogenesis and treatment","volume":"40","author":"Pinto","year":"2021","journal-title":"Clin Rheumatol"},{"key":"2025050906463368900_CIT0007","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/bor.0000000000000669","article-title":"A monogenic autoinflammatory disease with fatal vasculitis: deficiency of adenosine deaminase 2","volume":"32","author":"Sahin","year":"2020","journal-title":"Curr Opin Rheumatol"},{"key":"2025050906463368900_CIT0008","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s00296-017-3740-3","article-title":"Clinical, imaging and genotypical features of three deceased and five surviving cases with ADA2 deficiency","volume":"38","author":"Sahin","year":"2018","journal-title":"Rheumatol Int"},{"key":"2025050906463368900_CIT0009","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s10875-019-0590-7","article-title":"Childhood hodgkin lymphoma: think DADA2","volume":"39","author":"Alabbas","year":"2019","journal-title":"J Clin Immunol"},{"key":"2025050906463368900_CIT0010","doi-asserted-by":"publisher","first-page":"2050313X241260148","DOI":"10.1177\/2050313X241260148","article-title":"Deficiency of adenosine deaminase 2 leading to recurrent Hodgkin lymphoma: a case report","volume":"12","author":"Manhal","year":"2024","journal-title":"SAGE Open Med Case Rep"},{"issue":"5","key":"2025050906463368900_CIT0011","first-page":"480","article-title":"Mutant ADA2 in vasculopathies","volume":"371","author":"Van Eyck","year":"2014","journal-title":"N Engl J Med"},{"issue":"6","key":"2025050906463368900_CIT0012","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s10875-023-01484-w","article-title":"Whole exome sequencing reveals pathogenic variants in ADA2 and FAS causing DADA2 and ALPS","volume":"43","author":"Ahn","year":"2023","journal-title":"J Clin Immunol"},{"key":"2025050906463368900_CIT0013","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26912","article-title":"Deficiency of ADA2 mimicking autoimmune lymphoproliferative syndrome in the absence of livedo reticularis and vasculitis","volume":"65","author":"Alsultan","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"2025050906463368900_CIT0014","doi-asserted-by":"publisher","first-page":"754029","DOI":"10.3389\/fimmu.2021.754029","article-title":"Case report: Deficiency of adenosine deaminase 2 presenting with overlapping features of autoimmune lymphoproliferative syndrome and bone marrow failure","volume":"12","author":"Dell\u2019Orso","year":"2021","journal-title":"Front Immunol"},{"key":"2025050906463368900_CIT0015","doi-asserted-by":"publisher","first-page":"e293","DOI":"10.1097\/MPH.0000000000000805","article-title":"Refractory pure red cell aplasia manifesting as deficiency of adenosine deaminase 2","volume":"39","author":"Hashem","year":"2017","journal-title":"J Pediatr Hematol Oncol"},{"key":"2025050906463368900_CIT0016","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1080\/08820139.2020.1853153","article-title":"Adenosine deaminase type II deficiency: severe chronic neutropenia, lymphoid infiltration in bone marrow, and inflammatory features","volume":"51","author":"S\u00fcleyman","year":"2022","journal-title":"Immunol Invest"},{"key":"2025050906463368900_CIT0017","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s10875-018-0480-4","article-title":"Hematologic manifestations of deficiency of adenosine deaminase 2 (DADA2) and response to tumor necrosis factor inhibition in DADA2-associated bone marrow failure","volume":"38","author":"Michniacki","year":"2018","journal-title":"J Clin Immunol"},{"key":"2025050906463368900_CIT0018","doi-asserted-by":"publisher","first-page":"97","DOI":"10.21037\/tp-22-261","article-title":"ADA2 deficiency (DADA2) misdiagnosed as systemic onset juvenile idiopathic arthritis in a child carrying a novel compound heterozygous ADA2 mutation: a case report","volume":"12","author":"Yin","year":"2023","journal-title":"Transl Pediatr"},{"issue":"1","key":"2025050906463368900_CIT0019","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/mrcr\/rxad045","article-title":"A case with febrile attacks and vasculopathy associated with ADA2 and MEFV pathogenic variants","volume":"8","author":"Parlar","year":"2023","journal-title":"Mod Rheumatol Case Rep"},{"key":"2025050906463368900_CIT0020","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s10875-022-01328-z","article-title":"Deficiency of adenosine deaminase 2 presenting as periodic fever at the mainland of familial mediterranean fever","volume":"42","author":"\u00c7akan","year":"2022","journal-title":"J Clin Immunol"},{"issue":"3","key":"2025050906463368900_CIT0021","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s10875-022-01413-3","article-title":"ADA2 deficiency mimicking acute disseminated encephalomyelitis","volume":"43","author":"Ehlers","year":"2023","journal-title":"J Clin Immunol"},{"key":"2025050906463368900_CIT0022","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1080\/00325481.2022.2088940","article-title":"Polyarteritis nodosa: an evolving primary systemic vasculitis","volume":"135","author":"Springer","year":"2023","journal-title":"Postgrad Med"},{"key":"2025050906463368900_CIT0023","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/art.41549","article-title":"Sequence-based screening of patients with idiopathic polyarteritis nodosa, granulomatosis with polyangiitis, and microscopic polyangiitis for deleterious genetic variants in ADA2","volume":"73","author":"Schnappauf","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"2025050906463368900_CIT0024","doi-asserted-by":"publisher","first-page":"937108","DOI":"10.3389\/fimmu.2022.937108","article-title":"Case Report: Susceptibility to viral infections and secondary hemophagocytic lymphohistiocytosis responsive to intravenous immunoglobulin as primary manifestations of adenosine deaminase 2 deficiency","volume":"13","author":"Drago","year":"2022","journal-title":"Front Immunol"},{"key":"2025050906463368900_CIT0025","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1002\/art.40147","article-title":"Screening of 181 patients with antibody deficiency for deficiency of adenosine deaminase 2 sheds new light on the disease in adulthood","volume":"69","author":"Schepp","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2025050906463368900_CIT0026","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1007\/s10875-022-01291-9","article-title":"Distinct CD8 T cell populations with differential exhaustion profiles associate with secondary complications in common variable immunodeficiency","volume":"42","author":"Klocperk","year":"2022","journal-title":"J Clin Immunol"},{"key":"2025050906463368900_CIT0027","doi-asserted-by":"publisher","first-page":"23247096211056770","DOI":"10.1177\/23247096211056770","article-title":"Novel Adenosine Deaminase 2 (ADA2) mutations associated with hematological manifestations","volume":"9","author":"Albalawi","year":"2021","journal-title":"J Investig Med High Impact Case Rep"},{"key":"2025050906463368900_CIT0028","doi-asserted-by":"publisher","first-page":"e15288","DOI":"10.7759\/cureus.15288","article-title":"A novel variant of adenosine deaminase 2 deficiency presented with chronic thrombocytopenia, anemia, and early-onset stroke","volume":"13","author":"Al-Hebshi","year":"2021","journal-title":"Cureus"},{"key":"2025050906463368900_CIT0029","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.jpeds.2016.06.058","article-title":"Extending the clinical phenotype of adenosine deaminase 2 deficiency","volume":"177","author":"Ben-Ami","year":"2016","journal-title":"J Pediatr"},{"key":"2025050906463368900_CIT0030","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/s41572-021-00317-7","article-title":"Castleman disease","volume":"7","author":"Carbone","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"2025050906463368900_CIT0031","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12969-023-00838-3","article-title":"A case series of ten plus one deficiency of adenosine deaminase 2 (DADA2) patients in Iran","volume":"21","author":"Asna Ashari","year":"2023","journal-title":"Pediatr Rheumatol Online J"},{"key":"2025050906463368900_CIT0032","doi-asserted-by":"publisher","first-page":"e20172266","DOI":"10.1542\/peds.2017-2266","article-title":"ADA2 deficiency mimicking idiopathic multicentric castleman disease","volume":"142","author":"Van Nieuwenhove","year":"2018","journal-title":"Pediatrics"},{"key":"2025050906463368900_CIT0033","doi-asserted-by":"publisher","first-page":"e05408","DOI":"10.1002\/ccr3.5408","article-title":"Atypical presentation of adenosine deaminase 2 deficiency with bi-allelic ADA2 mutation","volume":"10","author":"Al-Shaikh","year":"2022","journal-title":"Clin Case Rep"},{"key":"2025050906463368900_CIT0034","doi-asserted-by":"publisher","first-page":"8331","DOI":"10.3390\/ijms22158331","article-title":"A novel germline mutation of ADA2 gene in two \u2018discordant\u2019 homozygous female twins affected by adenosine deaminase 2 deficiency: description of the bone-related phenotype","volume":"22","author":"Vai","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2025050906463368900_CIT0035","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1182\/blood-2016-05-717140","article-title":"Pure red cell aplasia","volume":"128","author":"Means","year":"2016","journal-title":"Blood"},{"key":"2025050906463368900_CIT0036","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s10875-024-01712-x","article-title":"Development of EBV related diffuse large B-cell lymphoma in deficiency of adenosine deaminase 2 with uncontrolled EBV infection","volume":"44","author":"Gardner","year":"2024","journal-title":"J Clin Immunol"},{"key":"2025050906463368900_CIT0037","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1016\/j.lpm.2018.08.014","article-title":"Familial mediterranean fever","volume":"48","author":"Ozdogan","year":"2019","journal-title":"Presse Med"},{"key":"2025050906463368900_CIT0038","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/s41584-023-01042-z","article-title":"Treatment of systemic juvenile idiopathic arthritis","volume":"19","author":"Hinze","year":"2023","journal-title":"Nat Rev Rheumatol"},{"key":"2025050906463368900_CIT0039","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13023-023-02721-6","article-title":"A wide spectrum of phenotype of deficiency of deaminase 2 (DADA2): a systematic literature review","volume":"18","author":"Maccora","year":"2023","journal-title":"Orphanet J Rare Dis"},{"key":"2025050906463368900_CIT0040","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1038\/s41431-018-0130-6","article-title":"A decision tree for the genetic diagnosis of deficiency of adenosine deaminase 2 (DADA2): a French reference centres experience","volume":"26","author":"Rama","year":"2018","journal-title":"Eur J Hum Genet"},{"key":"2025050906463368900_CIT0041","first-page":"630691","article-title":"Clinical spectrum and outcome of children with deficiency of adenosine deaminase 2 (DADA2): multicentric experience from India","volume":"12","author":"Kumar","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"2025050906463368900_CIT0042","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1016\/j.jaci.2021.10.030","article-title":"TNF inhibition in vasculitis management in adenosine deaminase 2 deficiency (DADA2)","volume":"149","author":"Deuitch","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"2025050906463368900_CIT0043","doi-asserted-by":"publisher","first-page":"102784","DOI":"10.1016\/j.autrev.2021.102784","article-title":"Biologic drugs in the treatment of polyarteritis nodosa and deficit of adenosine deaminase 2: a narrative review","volume":"20","author":"Conticini","year":"2021","journal-title":"Autoimmun Rev"},{"key":"2025050906463368900_CIT0044","doi-asserted-by":"publisher","first-page":"13","DOI":"10.18176\/jiaci.0748","article-title":"Treatment and outcome in deficiency of adenosine deaminase 2: A literature review","volume":"32","author":"Zhang","year":"2021","journal-title":"J Investig Allergol Clin Immunol"},{"key":"2025050906463368900_CIT0045","doi-asserted-by":"publisher","first-page":"4373","DOI":"10.1093\/rheumatology\/keaa837","article-title":"Anti-tumour necrosis factor treatment for the prevention of ischaemic events in patients with deficiency of adenosine deaminase 2 (DADA2)","volume":"60","author":"Cooray","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"2025050906463368900_CIT0046","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12969-023-00881-0","article-title":"Efficacy and safety of thalidomide in children with monogenic autoinflammatory diseases: a single-center, real-world-evidence study","volume":"21","author":"Zhang","year":"2023","journal-title":"Pediatr Rheumatol Online J"},{"key":"2025050906463368900_CIT0047","doi-asserted-by":"publisher","first-page":"e2315894","DOI":"10.1001\/jamanetworkopen.2023.15894","article-title":"Evaluation and management of deficiency of adenosine deaminase 2: an international consensus statement","volume":"6","author":"Lee","year":"2023","journal-title":"JAMA Netw Open"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cei\/advance-article-pdf\/doi\/10.1093\/cei\/uxaf017\/62521397\/uxaf017.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/219\/1\/uxaf017\/62521397\/uxaf017.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/219\/1\/uxaf017\/62521397\/uxaf017.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T10:46:41Z","timestamp":1746787601000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/doi\/10.1093\/cei\/uxaf017\/8090160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1,21]]}},"URL":"https:\/\/doi.org\/10.1093\/cei\/uxaf017","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025]]},"published":{"date-parts":[[2025]]},"article-number":"uxaf017"}}